AVMA news
Catalyzing the field of canine comparative oncology, benefiting researchers far and wide
The Comparative Oncology Program at the National Institutes of Health has transformed canine comparative oncology since the program’s founding 20…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
Cultivating research on cancer in dogs, from clinical trials down to the molecular level
The Comparative Oncology Program at the National Institutes of Health, which promotes the study of cancer in dogs, manages the Comparative Oncology…
AVMA news
Drugs treating epilepsy, feline diabetes receive FDA approval
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat idiopathic epilepsy in dogs and…
AVMA news
FDA approves generic drugs for use in cats, dogs, horses, ferrets
The Food and Drug Administration announced in January that the agency had approved new generic drugs for cats, dogs, and horses and granted a…
AVMA news
CDC eases entry requirements for dogs vaccinated in United States
The Centers for Disease Control and Prevention removed permit requirements for dogs returning to the U.S., effective Dec. 1, provided those dogs were…
AVMA news
Human-to-dog monkeypox transmission case reported
On June 10, a team from Sorbonne University in Paris recorded two human cases of infection with monkeypox virus connected with a case in a dog.